In Trading, Results Matter.
Our Top 10 exits in last 5 trading days.

Eiger Bio Pharmaceuticals, Inc.. Trade Record

NASDAQ:EIGR Eiger Bio Pharmaceuticals, Inc. stock gains 21.61% Exit Sep 5, 2018 a Trade Record by priceseries

Trade Chart
Trade Chart EIGR Aug 14, 2018, priceSeries
About Eiger Bio Pharmaceuticals, Inc.

Eiger BioPharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on providing various products for the treatment of orphan diseases in the United States. It portfolio of products include Sarasar, an indication for the hepatitis delta virus infection; Exendin, which is used for the treatment of hypoglycemia associated with bariatric surgery; and Bestatin that is used for the treatment of pulmonary arterial hypertension and lymphedema, which are under Phase II clinical trials. The company was founded in 2008 and is headquartered in Palo Alto, California.

Trade Information
Trade Type
LONG
ReliabilityScore™
94.64
Entry Date
Aug 14, 2018
Entry Price
10.05
Sell Date
Sep 5, 2018
Sell Price
12.22
Net Gain
21.61%
Hold Time
15 Trading Days